Bayesian Capital Management’s Conformis, Inc. Common Stock CFMS Stock Holding History

Bayesian Capital Management’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-496	Closed	-$2K	–	1111
2022 Q3	$2K	Sell	496 -132	-21%	-$917	﹤0.01%	661
2022 Q2	$6K	Hold	628	–	–	﹤0.01%	742
2022 Q1	$10K	Buy	+628	New	+$10.3K	﹤0.01%	753
2021 Q2	–	Sell	-444	Closed	-$11K	–	710
2021 Q1	$11K	Buy	+444	New	+$12K	﹤0.01%	513

Other funds holding CFMS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWE

Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's CFMS Position: Q4 2022 in Review

Bayesian Capital Management sold out of Conformis, Inc. Common Stock (CFMS) in Q4 2022, closing a stake of 496 shares — an estimated $2K sold.

Bayesian Capital Management first reported a position in CFMS in Q1 2021 and held it in 4 quarters. The position peaked at $11K in Q1 2021. 35 funds tracked by Wall St. Rank hold CFMS as of Q4 2022.

Bayesian Capital Management reported no remaining Conformis, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bayesian Capital Management sold 496 Conformis, Inc. Common Stock shares in Q4 2022, an estimated $2K.
Bayesian Capital Management first reported a position in Conformis, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Bayesian Capital Management's Conformis, Inc. Common Stock position peaked at $11K in Q1 2021.
35 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.